3. Eczema and Dermatitis

Learning Objectives

• Distinguish eczema (atopic dermatitis) from the broader category of dermatitis
• Describe the clinical features and typical distribution of atopic, contact, and seborrheic dermatitis
• Explain the pathophysiology of atopic dermatitis, including the filaggrin/skin-barrier defect and Th2-driven inflammation
• Differentiate irritant contact dermatitis from allergic contact dermatitis, including the role of patch testing
• Apply a stepwise treatment approach using emollients, topical corticosteroids, and second-line agents
• Recognize complications of chronic dermatitis, including secondary infection and lichenification

Quick Answer

Eczema (atopic dermatitis) is a chronic, relapsing, itchy inflammatory skin condition driven by a defective skin barrier and an overactive Th2 immune response, most often starting in childhood. "Dermatitis" is the broader umbrella term for any inflamed, itchy skin — atopic dermatitis is just one type. Other common forms include contact dermatitis (irritant or allergic), seborrheic dermatitis, nummular dermatitis, and dyshidrotic eczema. All types share pruritus, erythema, and a disrupted skin barrier, but their triggers and distributions differ: atopic dermatitis favors flexural creases, allergic contact dermatitis follows the exact shape of the exposure, and seborrheic dermatitis targets sebum-rich areas like the scalp and nasolabial folds. Management centers on barrier repair with emollients, anti-inflammatory therapy with topical corticosteroids or calcineurin inhibitors, and trigger avoidance.

This page is for educational purposes. Always verify with current clinical guidelines.

What Is Eczema?

"Eczema" is the everyday name for atopic dermatitis (AD), a chronic, itchy, relapsing inflammatory skin disease. It is the most common chronic skin disease of childhood, often appearing before age 5, and it clusters with the other members of the "atopic triad" — asthma and allergic rhinitis. Many patients with AD have all three, and a family history of atopy is one of the strongest risk factors.

Clinically, AD looks different depending on age:

• Infants: red, weeping, crusted patches on the cheeks and extensor surfaces (the face is spared the flexural pattern seen later because infants crawl on extensor surfaces)
• Children and adults: dry, scaly, lichenified (thickened, leathery) plaques in the flexural creases — antecubital and popliteal fossae, neck, and wrists
• All ages: intense pruritus, often worse at night, with a cycle of scratching that worsens the barrier defect ("the itch that rashes," not the other way around)

What Is Dermatitis?

Dermatitis simply means "inflammation of the skin." It is a descriptive umbrella term, not a single disease — atopic dermatitis is one type of dermatitis, but not every dermatitis is eczema. Recognizing this distinction matters clinically because the workup and treatment differ by subtype even though they can look superficially similar (red, itchy, sometimes weeping skin).

Types of Eczema and Dermatitis

Type	Typical trigger	Classic distribution
Atopic dermatitis	Genetic barrier defect + environmental triggers	Flexural creases (antecubital, popliteal)
Irritant contact dermatitis	Direct chemical/physical damage (soaps, water, friction)	Hands; sharply confined to contact area
Allergic contact dermatitis	Delayed (type IV) hypersensitivity to an allergen	Shape mimics the exposure (e.g., linear streaks from poison ivy, earlobe from nickel earrings)
Seborrheic dermatitis	Malassezia yeast overgrowth + sebum	Scalp, eyebrows, nasolabial folds, chest
Nummular dermatitis	Often dry skin/xerosis; can follow injury	Coin-shaped ("nummular") plaques on extremities
Dyshidrotic eczema	Stress, sweating, metal (nickel) exposure	Small, intensely itchy vesicles on palms/soles and finger sides

Pathophysiology

Atopic dermatitis results from two intertwined problems:

1. Skin barrier dysfunction — Many patients carry loss-of-function mutations in the filaggrin (FLG) gene. Filaggrin is essential for forming the stratum corneum's protective structure. Without it, water loss increases (transepidermal water loss) and allergens/irritants penetrate more easily.
2. Immune dysregulation — The compromised barrier allows allergens to trigger a Th2-skewed immune response, releasing IL-4, IL-13, and IL-31 (the itch cytokine). This drives inflammation, IgE elevation, and the itch-scratch cycle that further damages the barrier.

Contact dermatitis has a different mechanism: irritant contact dermatitis is direct cytotoxic damage from a substance (no immune sensitization required, and it can occur on first exposure), while allergic contact dermatitis is a type IV (delayed, T-cell mediated) hypersensitivity reaction that requires prior sensitization and typically appears 24-72 hours after re-exposure.

Diagnosis

Diagnosis is largely clinical, based on morphology, distribution, chronicity, and history (personal or family atopy). Additional tools are used selectively:

• Clinical examination and history — first-line for all types; distribution pattern is often diagnostic
• Patch testing — the gold standard for confirming allergic contact dermatitis; patches are applied and read at 48 and 96 hours
• Skin biopsy — reserved for atypical presentations or to exclude mimics (e.g., cutaneous T-cell lymphoma, psoriasis)
• Serum IgE / eosinophil count — may be elevated in atopic dermatitis but are not diagnostic on their own

Treatment Options

Treatment follows a stepwise approach matched to severity:

• Emollients — the foundation of every regimen; thick, fragrance-free moisturizers applied liberally and frequently to repair the barrier and reduce flares
• Topical corticosteroids — first-line anti-inflammatory therapy; potency is matched to body site (low potency for face/skin folds, higher potency for thick plaques on trunk/limbs)
• Topical calcineurin inhibitors (tacrolimus, pimecrolimus) — steroid-sparing option, particularly useful on the face and eyelids where chronic steroid use causes atrophy
• Oral antihistamines — help with sleep disruption from nocturnal itch, though they do not directly treat the inflammation
• Phototherapy (narrowband UVB) — for moderate-to-severe disease unresponsive to topical therapy
• Systemic agents (dupilumab, JAK inhibitors, cyclosporine) — reserved for severe, refractory atopic dermatitis; dupilumab blocks IL-4/IL-13 signaling directly
• Trigger avoidance — identifying and eliminating the causative allergen or irritant is essential and curative for allergic/irritant contact dermatitis

Prevention Strategies

• Daily emollient use, especially after bathing, to maintain barrier integrity ("soak and seal")
• Identifying and avoiding known triggers (harsh soaps, wool fabrics, specific allergens identified on patch testing)
• Using lukewarm (not hot) water and limiting bathing time, which strips barrier lipids
• Wearing protective gloves/clothing when occupational or household irritant exposure is unavoidable
• Managing stress, which can exacerbate flares through neuro-immune pathways

Complications

• Secondary bacterial infection, most commonly Staphylococcus aureus, presenting as honey-crusted or weeping lesions
• Eczema herpeticum — disseminated HSV infection superimposed on eczematous skin; a dermatologic emergency requiring prompt antiviral therapy
• Lichenification — thickened, leathery skin from chronic scratching
• Post-inflammatory hyper- or hypopigmentation, especially in darker skin types
• Sleep disturbance and psychological impact from chronic pruritus, which can affect quality of life as much as the skin findings themselves

Case Studies

Example 1: Atopic Dermatitis in an Adult

Mrs. Smith, a 35-year-old office worker with a childhood history of asthma and hay fever, presents with chronic, intensely itchy plaques in both antecubital fossae and on her hands, worse in winter. Her presentation fits classic adult atopic dermatitis: flexural distribution, personal atopic history, and seasonal flare pattern. Management: liberal emollients, a moderate-potency topical corticosteroid for flares, and a discussion of hand protection given her frequent handwashing at work.

Example 2: Allergic Contact Dermatitis in a Child

Timmy, a 7-year-old boy, develops sharply demarcated red, itchy patches on the areas of skin that touched a new metal toy. The confined, shape-matching distribution points away from atopic dermatitis and toward allergic contact dermatitis. Patch testing confirms a nickel allergy. Treatment is straightforward once the trigger is identified: avoid nickel-containing items, use a short course of topical corticosteroids for the acute rash, and educate the family on reading product labels ("nickel-free" jewelry and fasteners).

Key Terms

Term	Definition	Related Concept
Atopic dermatitis	Chronic relapsing eczema linked to barrier dysfunction and Th2 inflammation	Atopic triad (asthma, rhinitis, eczema)
Filaggrin	Structural protein essential for skin barrier integrity; loss-of-function mutations predispose to AD	Transepidermal water loss
Irritant contact dermatitis	Direct chemical/physical skin damage, no sensitization needed	Occupational hand dermatitis
Allergic contact dermatitis	Type IV (delayed) hypersensitivity reaction to a specific allergen	Patch testing, nickel/poison ivy allergy
Seborrheic dermatitis	Inflammatory condition linked to Malassezia yeast in sebum-rich skin	Dandruff, cradle cap
Lichenification	Thickened, leathery skin from chronic rubbing/scratching	Chronic atopic dermatitis
Pruritus	The sensation of itch; mediated by histamine and cytokines like IL-31	Itch-scratch cycle
Eczema herpeticum	Disseminated HSV infection on eczematous skin; a dermatologic emergency	Secondary infection
Patch testing	Diagnostic application of allergens to skin, read at 48 and 96 hours	Allergic contact dermatitis
Dupilumab	Monoclonal antibody blocking IL-4/IL-13 receptor signaling	Biologic therapy for severe AD

Common Mistakes

Misconception: Eczema and dermatitis are two different diseases. Why it's wrong: Students often treat these as separate entities to memorize independently. Correct understanding: Dermatitis is the general category (skin inflammation); eczema/atopic dermatitis is one specific, common type within that category. Contact and seborrheic dermatitis are other types of dermatitis, not separate from it.

Misconception: Any red, itchy rash that follows skin contact with a substance must be an allergy. Why it's wrong: This ignores irritant contact dermatitis, which is far more common than allergic contact dermatitis and does not involve the immune system at all. Correct understanding: Irritant contact dermatitis results from direct chemical or physical damage and can occur on the very first exposure. Allergic contact dermatitis requires prior sensitization and is confirmed by patch testing, not just a temporal association with an exposure.

Misconception: Moisturizers are optional and less important than prescription medication. Why it's wrong: Many patients and even some clinicians view emollients as a "nice-to-have" adjunct rather than core therapy. Correct understanding: Emollients are foundational treatment, not an afterthought. Regular emollient use repairs the barrier defect that drives atopic dermatitis, reduces flare frequency, and often reduces the amount of topical steroid needed.

Comparison and Connections

Feature	Atopic Dermatitis	Irritant Contact Dermatitis	Allergic Contact Dermatitis	Seborrheic Dermatitis
Mechanism	Barrier defect + Th2 immune response	Direct toxic/physical damage	Type IV hypersensitivity	Malassezia yeast overgrowth
Onset	Chronic, relapsing, often childhood	Can occur on first exposure	Requires prior sensitization; 24-72h delay	Chronic, waxing/waning
Distribution	Flexural creases	Confined to contact area	Shape matches exposure	Scalp, eyebrows, nasolabial folds
Diagnostic test	Clinical; IgE sometimes elevated	Clinical/history	Patch testing	Clinical; KOH if unclear
Key treatment	Emollients + topical steroids/calcineurin inhibitors	Barrier protection + irritant avoidance	Allergen avoidance + topical steroids	Antifungal shampoo/cream (ketoconazole)

Practice Questions

Recall

1. What is the umbrella relationship between "dermatitis" and "eczema"? Answer guidance: Dermatitis is the general term for skin inflammation; eczema (atopic dermatitis) is one specific subtype of dermatitis.

2. Name the gold-standard diagnostic test for allergic contact dermatitis and when it is read. Answer guidance: Patch testing, read at 48 and 96 hours after application.

Understanding

3. Why does atopic dermatitis classically affect flexural creases in older children and adults but the extensor/facial surfaces in infants? Answer guidance: Infants crawl and rub extensor surfaces against surfaces, and the flexural pattern isn't yet established; as children age and mobility patterns change, sweat retention and friction in flexural creases (antecubital/popliteal fossae) become the dominant distribution.

4. Explain why irritant contact dermatitis can occur after a single exposure but allergic contact dermatitis cannot. Answer guidance: Irritant dermatitis is direct chemical/physical damage requiring no immune involvement, so it can happen immediately. Allergic contact dermatitis is a type IV hypersensitivity reaction that requires an initial sensitization phase before the immune system can mount a reaction on re-exposure.

Application

5. A construction worker develops red, cracked, painful skin on both hands after months of wearing wet gloves, with no history of new products. What is the most likely diagnosis and first-line management? Answer guidance: Irritant contact dermatitis from prolonged moisture/friction. Management: barrier creams, glove liners, reducing wet-work exposure, and emollients rather than allergen avoidance.

6. A patient presents with a linear, streaky, intensely itchy rash on the forearm after gardening. What test would confirm the suspected diagnosis, and what is the likely culprit? Answer guidance: Patch testing (though a classic linear streak from poison ivy/oak is often diagnosed clinically); urushiol is the classic allergen, causing allergic contact dermatitis.

Analysis

7. A 6-month-old with facial eczema and a strong family history of asthma is later found to have peanut allergy. How are these findings connected pathophysiologically? Answer guidance: The "atopic march" — a defective skin barrier (e.g., filaggrin mutation) allows environmental allergens, including food proteins, to penetrate through inflamed skin and sensitize the immune system, contributing to subsequent food allergy, asthma, and allergic rhinitis.

8. Compare the diagnostic and management approach for a patient with suspected seborrheic dermatitis versus atopic dermatitis on the scalp of an infant (cradle cap vs. infantile eczema). Answer guidance: Seborrheic dermatitis (cradle cap) presents with greasy yellow scales on the scalp and is treated with gentle scalp emollients/antifungal shampoo, while infantile atopic dermatitis is drier, more diffusely itchy, and typically involves cheeks/extensor surfaces, requiring emollients and possibly low-potency topical steroids. Distinguishing them matters because antifungal treatment does not address the barrier/immune driver of AD.

FAQ

Q: Is eczema contagious? No. Eczema (atopic dermatitis) is not caused by an infection and cannot be spread by contact. However, eczematous skin has a disrupted barrier, so patients are more susceptible to picking up infections like Staphylococcus aureus or herpes simplex (eczema herpeticum) from others — it's the secondary infection that can spread, not the eczema itself.

Q: Will my child outgrow their eczema? Many children do improve significantly by adolescence, though the barrier defect and atopic tendency often persist at a subclinical level. Some patients continue to have flares into adulthood, particularly on the hands, and a subset develops other atopic conditions (asthma, allergic rhinitis) as the "eczema" itself improves — a pattern called the atopic march.

Q: How do I tell if my rash is an allergy or an irritation? Timing and shape are the biggest clues. Irritant reactions can appear after a single exposure and are usually confined exactly to where the substance touched. Allergic reactions typically take 24-72 hours to develop after re-exposure to something you've been exposed to before, and definitive confirmation requires patch testing.

Q: Why do doctors emphasize moisturizer so much for eczema? Because atopic dermatitis starts with a broken skin barrier. Moisturizers (emollients) restore that barrier, reduce water loss, and make the skin less permeable to irritants and allergens. Studies show consistent emollient use reduces both flare frequency and the amount of topical steroid needed — it is treatment, not just comfort care.

Q: Are topical steroids dangerous for long-term eczema management? Used correctly, topical steroids are safe and effective. The risk of side effects (skin thinning, striae, telangiectasia) rises with high-potency steroids used long-term on thin skin (face, groin, skin folds). The solution is matching potency to site and duration, using steroid-sparing agents like calcineurin inhibitors on sensitive areas, and following a clinician's tapering plan rather than avoiding steroids altogether out of "steroid phobia."

Quick Revision

• Dermatitis = umbrella term for skin inflammation; eczema (atopic dermatitis) is one type of dermatitis, not a separate category
• Atopic dermatitis is driven by filaggrin barrier defects plus Th2-mediated inflammation (IL-4, IL-13, IL-31)
• Classic AD distribution: flexural creases in children/adults; extensor/facial surfaces in infants
• Atopic triad: eczema, asthma, allergic rhinitis (the "atopic march")
• Irritant contact dermatitis: direct damage, no sensitization needed, can occur on first exposure
• Allergic contact dermatitis: type IV hypersensitivity, requires prior sensitization, confirmed by patch testing (read at 48 and 96 hours)
• Seborrheic dermatitis: linked to Malassezia yeast, affects sebum-rich areas (scalp, nasolabial folds)
• First-line treatment for all eczematous conditions: emollients plus topical corticosteroids matched to site potency
• Calcineurin inhibitors (tacrolimus/pimecrolimus) are steroid-sparing options for the face/eyelids
• Eczema herpeticum is a dermatologic emergency — disseminated HSV on eczematous skin
• Dupilumab (anti-IL-4/IL-13) is reserved for severe, refractory atopic dermatitis
• Trigger avoidance is curative for allergic and irritant contact dermatitis once the cause is identified

Related Topics

Prerequisites: Skin structure and barrier function (epidermis, filaggrin), basic immunology (Th1/Th2 responses, type IV hypersensitivity)

Related Topics: Introduction to Dermatology (skin layers, diagnostic techniques), Immunology (hypersensitivity reactions), Pharmacology (topical corticosteroid potency classes, biologics)

Next Topics: Psoriasis and Other Dermatoses, Skin Infections and Infestations, Urticaria and Angioedema